Skip to content

Clinical trials

Phase 2 Systemic Inflammatory Response Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Systemic Inflammatory Response Syndrome Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20082
20101
20141
20151
20162
20182
20191
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CalciMedica, Inc.2
Christian Hassager2
InflaRx GmbH2
Ottawa Hospital Research Institute2
AstraZeneca1
Austin Health1
Canadian Critical Care Trials Group1
Eisai Inc.1
Imperial College London1
Leading BioSciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Systemic Inflammatory Response Syndrome16
Sepsis6
Shock, Septic6
Infections5
Inflammation5
Shock4
Pathologic Processes3
Heart Arrest2
Out-of-Hospital Cardiac Arrest2
Pancreatitis2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.